Laxmi Dental Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has received formal approvals from both National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) for the listing and trading of 59,360 equity shares issued under its Employee Stock Option Scheme 2024.
Approval Details
- NSE Approval: Received via letter Ref.: NSE/LIST/2026/57193 dated August 31, 2026
- BSE Approval: Received via letter LOD / ESOP / TP/ No. 10/ 2026-27 dated August 31, 2026
Security Details
- Type of Security: Equity Shares
- Face Value: ₹2 per share
- Total Quantity: 59,360 shares
- Distinctive Numbers: 54962150 to 55021509
- Trading Commencement: September 1, 2026 on both exchanges
Additional Information
The approval letters from both exchanges have been enclosed with the disclosure and will be made available on the company's website (www.laxmidentallimited.com).
Both exchanges have provided instructions for future submissions:
- NSE requires use of "NEAPS" (NSE Electronic Application Processing System) at https://neaps.nseindia.com/NEWLISTINGCORP/Y
- BSE requires use of its "listing centre" portal as per notice no. 20151210-19 dated December 10, 2015
The disclosure was signed by Suman Saha, Company Secretary and Compliance Officer (Membership Number: A33035) on behalf of Laxmi Dental Limited.